Related Experiment Video
Updated: Jul 5, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Left ventricular remodeling and its association with mineral and bone disorder in kidney transplant recipients
Li Sun1, Dongliang Zhang2, Jiawen Liu1
1Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Insights
Left ventricular remodeling partially improved one year after kidney transplant, with changes linked to mineral and bone disorder. Key factors influencing these cardiac changes were identified.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Mineral and bone disorder (MBD) and its impact on cardiac remodeling in kidney transplant recipients (KTRs) remain understudied.
- Kidney transplantation (KT) significantly alters systemic metabolism, potentially affecting cardiovascular health.
- Systematic evaluation of LV remodeling post-KT and its association with MBD is needed.
Purpose of the Study:
- To assess changes in left ventricular (LV) remodeling one year after kidney transplantation (KT).
- To identify factors influencing LV remodeling in KTRs, particularly those related to MBD.
- To explore the relationship between MBD and LV remodeling post-KT.
Main Methods:
- Prospective follow-up of 95 KTRs before and one year after KT.
- Assessment of traditional risk factors and bone metabolism indicators.
- Echocardiographic measurement of LV mass index (LVMI), ejection fraction (LVEF), and diastolic dysfunction (LVDD).
Main Results:
- One year post-KT, MBD markers showed partial improvement, alongside decreased LVMI, left ventricular hypertrophy (LVH), and LVDD, and increased LVEF.
- LVH correlated with postoperative intact parathyroid hormone (iPTH) levels.
- Factors like age, BMI, diabetes, dialysis duration, and lipid profiles were associated with LV remodeling.
Conclusions:
- Left ventricular remodeling demonstrates partial improvement following kidney transplantation.
- The observed cardiac remodeling changes are closely associated with the status of mineral and bone disorder.
Background:
The assessment of left ventricular (LV) remodeling and its association with mineral and bone disorder (MBD) in kidney transplant recipients (KTRs) have not been systematically studied. We aimed to evaluate LV remodeling changes one year after kidney transplantation (KT) and identify their influencing factors.
Methods:
Ninety-five KTRs (68 males; ages 40.2 ± 10.8 years) were followed before and one year after KT. Traditional risk factors and bone metabolism indicators were assessed. Left ventricular mass index (LVMI), left ventricular ejection fraction (LVEF) and left ventricular diastolic dysfunction (LVDD) were measured using two-dimensional transthoracic echocardiography. The relationship between MBD and LV remodeling and the factors influencing LV remodeling were analyzed.
Results:
One year after KT, MBD was partially improved, mainly characterized by hypercalcemia, hypophosphatemia, hyperparathyroidism, 25-(OH) vitamin D deficiency, elevated bone turnover markers, and bone loss. LVMI, the prevalence of left ventricular hypertrophy (LVH), and the prevalence of LVDD decreased, while LVEF increased. LVH was positively associated with postoperative intact parathyroid hormone (iPTH) and iPTH nonnormalization. △LVMI was positively associated with preoperative type-I collagen N-terminal peptide and postoperative iPTH. LVEF was negatively associated with postoperative phosphorous. △LVEF was negatively associated with postoperative iPTH. LVDD was positively associated with postoperative lumbar spine osteoporosis. Preoperative LVMI was negatively associated with △LVMI and positively associated with △LVEF. Advanced age, increased BMI, diabetes, longer dialysis time, lower albumin level, and higher total cholesterol and low-density lipoprotein levels were associated with LV remodeling.
Conclusions:
LV remodeling partially improved after KT, showing a close relationship with MBD.
Related Concept Videos
Bone Remodeling
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling

